Louise Serpell

Prof. Louise Serpell


Research Focus & Metrics

Academic Career Length

32Years (1995-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 1997 in Journal of Molecular Biology
Verified
Journal Article
Closed access
MSMargaret Sunde
Margaret Sunde
LSLouise Serpell
Louise Serpell
MBMark Bartlam
Mark Bartlam
PFPaul E Fraser
Paul E Fraser
MPMark B Pepys
Mark B Pepys
CBColin C.F Blake
Colin C.F Blake

1 June 2014 in Neuron
Verified
Journal Article
Closed access
DSDavid W. Sanders
David W. Sanders
SKSarah K. Kaufman
Sarah K. Kaufman
SDSarah L. DeVos
Sarah L. DeVos
ASApurwa M. Sharma
Apurwa M. Sharma
HMHilda Mirbaha
Hilda Mirbaha
MDMarc I. Diamond
Marc I. Diamond

25 August 2000 in Science
Verified
Journal Article
Closed access
PDF file
TSTricia R. Serio
Tricia R. Serio
ACAnil G. Cashikar
Anil G. Cashikar
AKAnthony S. Kowal
Anthony S. Kowal
GSGeorge J. Sawicki
George J. Sawicki
JMJahan J. Moslehi
Jahan J. Moslehi
SLSusan L. Lindquist
Susan L. Lindquist
Prion proteins can serve as genetic elements by adopting distinct physical and functional states that are self-perpetuating and heritable. The critical region of one prion protein, Sup35, is initially unstructured in solution and then forms self-seeded amyloid fibers. We examined in vitro the mechanism by which this state is attained and replicated. Structurally fluid oligomeric complexes appear to be crucial intermediates in de novo amyloid nucleus formation. Rapid assembly ensues when these complexes conformationally convert upon association with nuclei. This model for replicating protein-based genetic information, nucleated conformational conversion, may be applicable to other protein assembly processes.

1 July 2000 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
LSLouise Serpell
Louise Serpell

25 April 2000 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
LSLouise Serpell
Louise Serpell
JBJohn Berriman
John Berriman
RJRoss Jakes
Ross Jakes
MGMichel Goedert
Michel Goedert
RCR. Anthony Crowther
R. Anthony Crowther
Filamentous inclusions made of α-synuclein constitute the defining neuropathological characteristic of Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy. Rare familial cases of Parkinson's disease are associated with mutations A53T and A30P in α-synuclein. We report here the assembly properties and secondary structure characteristics of recombinant α-synuclein. Carboxy-terminally truncated human α-synuclein (1–87) and (1–120) showed the fastest rates of assembly, followed by human A53T α-synuclein, and rat and zebra finch α-synuclein. Wild-type human α-synuclein and the A30P mutant showed slower rates of assembly. Upon shaking, filaments formed within 48 h at 37°C. The related proteins β- and γ-synuclein only assembled after several weeks of incubation. Synthetic human α-synuclein filaments were decorated by an antibody directed against the carboxy-terminal 10 amino acids of α-synuclein, as were filaments extracted from dementia with Lewy bodies and multiple system atrophy brains. Circular dichroism spectroscopy indicated that α-synuclein undergoes a conformational change from random coil to β-sheet structure during assembly. X-ray diffraction and electron diffraction of the α-synuclein assemblies showed a cross-β conformation characteristic of amyloid.

14 February 2010 in Nature Methods
Verified
Journal Article
Closed access
PDF file
SMSebastian Maurer-Stroh
Sebastian Maurer-Stroh
MDMaja Debulpaep
Maja Debulpaep
NKNico Kuemmerer
Nico Kuemmerer
MPManuela Lopez de la Paz
Manuela Lopez de la Paz
Ivo MartinsIvo Martins
Ivo Martins
FRFrederic Rousseau
Frederic Rousseau